NYSE:IMS IMS Health (IMS) Stock Price, News & Analysis → Better than Bitcoin? The Biotech Stock with 46,751% Potential (From Behind the Markets) (Ad) Free IMS Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Share Share Today's Range$31.34▼$31.3450-Day Range N/A52-Week Range$22.36▼$31.59VolumeN/AAverage Volume1.27 million shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get IMS Health alerts: Email Address Ad Weiss RatingsThe Next Step of Their Control Is Here …Earlier this week, Section 702 of the Foreign Intelligence Surveillance Act (FISA) was renewed for an additional two years. What does this mean? It means the government has more time — and more ways — to surveil and control you.4 simple steps to protect your privacy and money before it’s too late. About IMS Health Stock (NYSE:IMS)IMS Health Holdings, Inc. (IMS) is an information and technology services company that provides solutions to its clients in the healthcare industry. The Company has its presence in over 100 countries. The Company's data set contains over 10 petabytes of data and over 500 million patient records. It serves healthcare organizations and life science companies, including pharmaceutical, biotechnology, consumer health and medical device manufacturers, as well as distributors, providers, payers, government agencies, policymakers, researchers and the financial community. The Company's principal information offerings include national information offerings, sub-national information offerings and OneKey. Its technology services offerings include technology solutions, real-world evidence solutions, and workflow analytics and consulting services. It offers technology services that include data warehousing, information technology (IT) outsourcing, software applications and other services.Read More Ad Weiss RatingsThe Next Step of Their Control Is Here …Earlier this week, Section 702 of the Foreign Intelligence Surveillance Act (FISA) was renewed for an additional two years. What does this mean? It means the government has more time — and more ways — to surveil and control you.4 simple steps to protect your privacy and money before it’s too late. IMS Stock News HeadlinesApril 26, 2024 | msn.com14 Experts Explain How to Take a More Intentional Approach to InnovationApril 26, 2024 | bizjournals.comA Gaithersburg firm just secured $35M from a longtime backerApril 26, 2024 | Weiss Ratings (Ad)Protect Yourself While There’s Still Time …The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.April 22, 2024 | msn.comHims & Hers Health, Inc. (HIMS) Stock Sinks As Market Gains: What You Should KnowApril 21, 2024 | msn.comBreak mental health stigma: Tips to address social anxiety in teensApril 18, 2024 | msn.comNeed to re-introduce Indian Medical Service to boost public healthcare sector, say medical expertsApril 17, 2024 | msn.comTerminally ill Hoosier celebrates final Indy 500 with IMS President Doug Boles, Sandi PattyApril 16, 2024 | msn.comFashion, gourmet food coming to IMS for Opulence at the Speedway on qualifying weekendApril 26, 2024 | Weiss Ratings (Ad)Protect Yourself While There’s Still Time …The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.April 16, 2024 | msn.comHigh Standards: Axxela Retains Global CertificationApril 16, 2024 | msn.comCaplin Steriles gets USFDA approval for its eye infection treatmentApril 14, 2024 | msn.comVisions du Réel Lebanese Doc ‘We Are Inside’ Debuts Trailer: ‘It’s About Change in My Father, in Me, in My Country’ (EXCLUSIVE)April 14, 2024 | msn.comTerminally ill Hoosier celebrating final Indy 500 with IMS President Doug Boles, Sandi PattyApril 11, 2024 | msn.comAxxela gets ISO recertificationApril 10, 2024 | msn.comHow Many Calories Can You Burn Swimming? Cardio, Strength, And Weight Loss Benefits Of Swim WorkoutsApril 10, 2024 | msn.comOptometrist discusses symptoms of eclipse-related eye damageApril 9, 2024 | msn.comRoyal Expert Says Prince Harry Is in a "Painful Place" With Kate MiddletonApril 9, 2024 | msn.comUSFDA grants approval to Strides Pharma for its anti-depressant drugApril 9, 2024 | msn.comIMS: More than 50,000 people attended eclipse eventApril 8, 2024 | finance.yahoo.comNava Health to Open Sixth Center in the Baltimore-Washington Metropolitan AreaApril 8, 2024 | msn.comEclipse time is here! When is today's 2024 total solar eclipse? What's the path of totality?April 3, 2024 | msn.comRev 2024 announces hosts, including 13News teamApril 1, 2024 | msn.comSevere thunderstorm watch issued in central, southern IndianaApril 1, 2024 | msn.comMan shot, killed on near southwest sideApril 1, 2024 | yahoo.comThe eclipse is one week away! What to know on solar glasses, time, Indiana path of totalityApril 1, 2024 | msn.comWhiteland couple rebuilds home after tornado destroyed itMarch 31, 2024 | msn.comWhat channel is NASCAR on today? TV schedule, start time for 2024 Richmond raceSee More Headlines Receive IMS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for IMS Health and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings7/27/2016Today4/26/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorN/A Industry N/A Sub-IndustryN/A Current SymbolNYSE:IMS CUSIPN/A CIK1595262 Webwww.imshealth.com Phone+1-203-4484600FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A The Best High-Yield Dividend Stocks for 2024Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.Get This Free Report IMS Stock Analysis - Frequently Asked Questions How were IMS Health's earnings last quarter? IMS Health Holdings Inc (NYSE:IMS) released its quarterly earnings results on Wednesday, July, 27th. The information technology services provider reported $0.41 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.38 by $0.03. The information technology services provider had revenue of $802 million for the quarter, compared to the consensus estimate of $796.93 million. The business's revenue was up 112.4% compared to the same quarter last year. During the same quarter last year, the company posted $0.37 EPS. What other stocks do shareholders of IMS Health own? Based on aggregate information from My MarketBeat watchlists, some companies that other IMS Health investors own include Frontier Communications (FTR), Cognizant Technology Solutions (CTSH), Dollar Tree (DLTR), Oxford Immunotec Global (OXFD), Exact Sciences (EXAS), Ford Motor (F), Hertz Global (HTZ), Incyte (INCY), IQVIA (IQV) and This page (NYSE:IMS) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldThe A.I. story nobody is telling you (Read ASAP)TradeSmithHe Is Giving Away BitcoinCrypto Swap ProfitsTrump is sounding the alarmPreserve Gold Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding IMS Health Holdings Inc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
